Evidence map›Paper›PMID 22655036›Full record

ArticlePloS one2012

Cataract-causing defect of a mutant γ-crystallin proceeds through an aggregation pathway which bypasses recognition by the α-crystallin chaperone.

Kate L Moreau, Jonathan A King

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Kate L MoreauDepartment of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.
Jonathan A King
Massachusetts Institute of Technology · US

Funding

Folding &Misfolding of Parallel Beta-Helix ProteinsR01GM017980 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI KING, JONATHAN ALAN · 1985 to 2009
$4.9M
Human gammaD-Crystallin Folding Misfolding &Fibril FormR01EY015834 · NEI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI KING, JONATHAN ALAN · 2005 to 2014
$3.5M
MECHANISM OF DNA REPLICATION IN XENOPUS EXTRACTSF32GM017980 · NIGMS · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI WALTER, JOHANNES · 1995 to 1997
–
BACTERIOPHAGE ASSEMBLY AND ITS GENETIC CONTROLR37GM017980 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI KING, JONATHAN A · 1988 to 1997
–
NEI NIH HHS EY015834NEI NIH HHS R01 EY015834NIGMS NIH HHS F32 GM017980NIGMS NIH HHS GM17980NIGMS NIH HHS R01 GM017980
6 · The paper itself

Abstract

backgroundThe transparency of the eye lens depends upon maintenance of the native state of the γ- and β-crystallins, which is aided by the abundant chaperones αA- and αB-crystallin. Mature onset cataract, the leading cause of blindness worldwide, involves the polymerization of covalently damaged or partially unfolded crystallins into light-scattering aggregates. A number of single amino acid substitutions and truncations of γ-crystallins result in congenital cataract in both humans and mice, though in many cases the coupling between the protein alterations and the accumulation of aggregates is poorly defined. METHODOLOGY/PRINCIPAL

findingsWe have studied the aggregation properties and chaperone interactions of human γD-crystallin carrying substitutions of two buried core mutants, I90F and V75D, which cause congenital cataract in mice. The in vitro aggregation pathway competing with productive refolding was not altered by either substitution. Furthermore, this aggregation pathway for both mutant proteins--originating from a partially folded intermediate--was efficiently suppressed by αB-crystallin. Thus the cataract pathology was unlikely to be associated with a direct folding defect. The native state of wild-type human γD-crystallin exhibited no tendency to aggregate under physiological conditions. However both I90F and V75D native-like proteins exhibited slow (days) aggregation to high molecular weight aggregates under physiological conditions. The perturbed conformation of I90F was recognized and bound by both αA and αB chaperones. In contrast, the aggregation derived from the perturbed state of V75D was not suppressed by either chaperone, and the aggregating species were not bound by the chaperone. CONCLUSIONS/SIGNIFICANCE: The cataract phenotype of I90F in mice may be due to premature saturation of the finite α- crystallin pool. The V75D aggregation pathway and its escape from chaperone surveillance and aggregation suppression can account for the congenital cataract pathology of this mutant. Failure of chaperone recognition may be an important source of pathology for many other protein folding defects.

Indexed as

alpha-CrystallinsAmino Acid SubstitutionAnimalsCataractgamma-CrystallinsHumansLens, CrystallineMiceMutant ProteinsProtein ConformationProtein Interaction MappingProtein Refoldingalpha-Crystallinsgamma-CrystallinsMutant Proteins

Identifiers

PMID22655036
PMCPMC3360035
OpenAlexW2140364907

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.